ELX 03
Alternative Names: ELX-03; NB-84Latest Information Update: 18 Sep 2023
At a glance
- Originator Eloxx Pharmaceuticals
- Class Eye disorder therapies; Glycosides; Small molecules
- Mechanism of Action Ribosomal protein modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Retinal disorders